Irina Portier, PhD

Postdoc
University of Utah

Irina Portier, PhD, is a postdoctoral fellow at the University of Utah in the lab of Drs. Rondina and Campbell. She currently investigates the role of the mechanistic target of rapamycin (mTOR) pathway on platelets in different disease settings, such as malaria and aging. Dr. Portier is currently a postdoctoral fellow with the American Heart Association.

Presentation(s):

• OC 10.5 - Aging Activates Platelet mTOR to Induce Platelet Hyperreactivity

  Saturday, July 9, 2022
  2:00 PM – 2:15 PM

• OC 26.1 - Procoagulant Platelet – Neutrophil Interactions Exacerbate Ischemic Stroke

  Sunday, July 10, 2022
  2:45 PM – 3:00 PM

• PB0763 - The mTOR Pathway in Platelets Contributes to the Pathophysiology of Experimental Cerebral Malaria

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 72.1 - Platelet HMGB1 mediates pathological NET formation in Ischemic Stroke

  Wednesday, July 13, 2022
  10:15 AM – 10:30 AM